Trials and Noteworthy Treatments

			Treatment Next 25		Location		Last Updated
	Details		Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.		Bethesda, MD		04/22/2009
	Details		Quality of Life in Patients with Brain Tumors, Skull Base Tumors & Pituitary Adenomas Undergoing Surgical Resection		Santa Monica, CA		11/29/2008
	Details		Bevacizumab (Avastin) and Irinotecan (CPT-11) in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma		San Francisco, CA Washington, DC Chicago, IL Boston, MA Bethesda, MD Durham, NC Philadelphia, PA Pittsburgh, PA Memphis, TN Seattle, WA		11/08/2008
	Details		Gliogene: An International Brain Tumor Study		Houston, TX		07/24/2008
	Details		A Phase II Trial With Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Primary Brain Tumors and Progression After Standard Therapy		Copenhagen, Denmark		08/18/2007
	Details		Brain Mapping for Brain Tumors		Boston, MA		08/18/2007
	Details		Evaluation of a Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers		Cleveland, OH		05/01/2007
	Details		Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study)		, , Canada , Canada , Canada , Canada , Canada , Canada , Switzerland , Switzerland Auckland, New Zealand Perth, Western Australia, 6001, Australia Randwick, New South Wales, 2031, Australia Phoenix, AZ Downey, CA Loma Linda, CA Los Angeles, CA Los Angeles, CA Los Angeles, CA Madera, CA Oakland, CA Orange, CA Orange, CA Sacramento, CA San Francisco, CA Santa Barbara , CA Travis Air Force Base, CA Denver, CO Farmington, CT Washington, DC Washington, DC Wilmington, DE Atlanta, GA Macon, GA Savannah, GA Des Moines, IA Chicago, IL Chicago, IL Park Ridge, IL Indianapolis, IN Springfield, MA Baltimore, MD Ann Arbor, MI Detroit, MI Grand Rapids, MI Kalamazoo, MI Royal Oak, MI Royal Oak, MI Minneapolis, MN Rochester, MN Kansas City, MO Chapel Hill, NC Charlotte, NC Winston-Salem, NC Fargo, ND Omaha, NE Omaha, NE Brunswick, NJ Newark, NJ Paterson, NJ Summit, NJ Las Vegas, NV Albany, NY Bronx, NY Brooklyn, NY Brooklyn, NY Brooklyn, NY Brooklyn, NY New Hyde Park, NY New York, NY Stony Brook, NY Syracuse, NY Akron, OH Cincinnati, OH Cleveland, OH Columbus, OH Dayton, OH Toledo, OH Portland, OR Danville, PA Philadelphia, PA Pittsburgh, PA Sioux Falls, SD Johnson City, TN Knoxville, TN Nashville, TN Amarillo, TX Austin, TX Dallas, TX Houston, TX Lubbock, TX San Antonio, TX San Antonio, TX Temple, TX Norfolk, VA Seattle, WA Seattle, WA Spokane, WA Tacoma, WA Green Bay, WI Green Bay, WI Green Bay, WI La Crosse, WI Madison, WI Marshfield, WI Marshfield, WI Huntington, WV		10/12/2006
	Details		Pilot Randomized Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Patients With Primary Brain Tumors		Los Angeles, CA		05/29/2006
	Details		"Head Start" chemotherapy protocol for children less than 10 years old with newly diagnosed high grade primary brain tumors with intent to eliminate irradiation and abbreviate total duration of treatment to 6 months with resultant improved cure rate and quality of survival.		Oakland, CA		05/01/2006
	Details		Headstart II A Phase II study of two alternative intensive induction chemotherapy followed by consolidation with myeloablative chemotherapy and autologous stem cell rescue with or without subsequent radiation therapy for children less than 10 yrs of age newly diagnosed with malignant brain tumors		Oakland, CA		05/01/2006
	Details		Pharmacological intervention for learning impaired children surviving treatment for cancer.		Durham, NC		12/03/2005
	Details		Gamma Knife Radiosurgery		Smithtown, NY		12/03/2005
	Details		Gamma Knife Radiosurgery for Brain Tumors		La Jolla, CA		12/03/2005
	Details		Phase I trial of Temozolomide (Temodar) and O6-Benzylguanine (o6-bg)in pediatric patients with recurrent brain tumors.		Durham, NC		12/03/2005
	Details		A Phase I dose escalation trial of Temodar that will attempt to determine the maximum tolerated dose of Temodar (Temozolomide) when given by prolonged oral exposure to children with recurrent or progressive brain tumors.		New York, NY		12/03/2005
	Details		Gamma Knife Radiosurgery		Edison, NJ		12/03/2005
	Details		Gamma knife stereotactic radiosurgery for benign and malignant brain tumors and brain metastases.		Rockville Centre, NY		12/03/2005
	Details		Quality of Life Studies (There are 19 seperate studies listed here)		Durham, NC		12/03/2005
	Details		A Phase I/II Study of Reirradiation for Recurrent Pediatric Brain and Spinal Cord Tumors and Primary Glioblastoma Multiforme Using the Photon Radiosurgery System		Chicago, IL		11/27/2005
	Details		A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors		Bethesda, MD		11/27/2005
	Details		Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas		Lanne, Switzerland		11/27/2005
	Details		A Phase I, Molecular Biology, and Phase II Study of Lapatinib (GW572016) in Pediatric Patients with Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma		Washington, DC Chicago, IL Boston, MA Durham, NC Philadelphia, PA Pittsburgh, PA Memphis, TN Memphis, TN Houston, TX Seattle, WA		11/27/2005
	Details		Computer Assisted Stereotactic Navigation For Resection Of Brain Tumors In Children And Adults		Hackensack, NJ		11/27/2005
	Details		Double sequential high dose Thiotepa with autologous stem cell rescue for patients age <60 years with recurrent malignant brain cancer.		Los Angeles, CA		11/27/2005

News Stories

Sorry - There were no pages found that contain that search phrase.

Frequently Asked Questions

Pages On This Website

(Relevance) Page Title - click title to go to the page!